Apyx Medical Corporation
APYX
$3.98
-$0.10-2.45%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 57.81% | 42.37% | 45.22% | 51.83% | -1.60% |
| Total Depreciation and Amortization | 13.89% | -15.38% | -12.10% | -6.58% | -22.58% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -25.98% | -18.31% | -48.53% | -61.06% | -19.92% |
| Change in Net Operating Assets | -119.98% | 84.71% | 923.17% | -117.49% | -119.17% |
| Cash from Operations | 20.36% | 71.52% | 88.93% | -32.78% | -220.13% |
| Capital Expenditure | -239.22% | 8.30% | -57.14% | -163.44% | 12.07% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -239.22% | 8.30% | -57.14% | -163.44% | 12.07% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 20.00% | 0.00% | 0.00% | 99.95% | 61.54% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -133.86% | -- |
| Cash from Financing | 1,000.00% | 600.00% | 600.00% | -71.65% | -103.05% |
| Foreign Exchange rate Adjustments | -132.84% | -1,347.37% | -81.82% | 814.29% | -116.13% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 10.70% | 62.86% | 88.54% | -82.67% | -227.63% |